FdaApplication
NDA 021044
Identifiers
- fda_app_no: NDA021044
Properties
| Property | Value |
|---|---|
| applicant_name | PURDUE PHARMA LP |
| application_type | NDA |
| approval_date | 2004-09-24 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PALLADONE | HYDROMORPHONE HYDROCHLORIDE | 16MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PALLADONE | HYDROMORPHONE HYDROCHLORIDE | 12MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PALLADONE | HYDROMORPHONE HYDROCHLORIDE | 32MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PALLADONE | HYDROMORPHONE HYDROCHLORIDE | 24MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products